Nghiên cứu tỉ lệ nhiễm human papilloma virus ở phụ nữ có phết tế bào cổ tử cung bất thường và các yếu tốt liên quan

ật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

infection. Br J Cancer, Vol 82(7), pp.1332-1338.
54 Kjellberg L., Wang Z., Wiklund F., Edlund K., Angstrom T., Lenner P.,
et al. (1999). Sexual behaviour and papillomavirus exposure in cervical
intraepithelial neoplasia: a population-based case-control study. J Gen
Virol, Vol 80(2), pp.391-398.
55 Koskela P., Anttila T., Bjorge T., Brunsvig A. & Dillner J. (2000).
Chlamydia trachomatis infection as a risk factor for invasive cervical
cancer. Int J Cancer, Vol 85(1), pp.35-39.
56 Koutsky L. (1997). Epidemiology of genital human papillomavirus
infection. Am J Med, Vol 102(5A), pp.3-8.
57 Kulasingam S. L., Hughes J. P., Kiviat N. B., Mao C., Weiss N. S.,
Kuypers J. M., et al. (2002). Evaluation of human papillomavirus testing
in primary screening for cervical abnormalities: comparison of
sensitivity, specificity, and frequency of referral. Jama, Vol 288(14),
pp.1749-1757.
58 Lee S. H., Vigliotti V. S., Vigliotti J. S. & Pappu S. (2007). Routine
human papillomavirus genotyping by DNA sequencing in community
hospital laboratories. Infect Agent Cancer, Vol 2, pp.11.
59 Lehtinen M., Koskela P., Jellum E., Bloigu A. & Anttila T. (2002).
Herpes simplex virus and risk of cervical cancer: a longitudinal, nested
case-control study in the nordic countries. Am J Epidemiol, Vol 156(8),
pp.687-692.
60 Levi, J. E., Fink, M. C. S., Canto, C. L. M., Carretiero, N., Matsubara,
R., Linhares, I., et al. (2002). Human Papillomavirus prevalence, viral
load and cervical intraepithelial neoplasia in HIV-infected women.

Brazilian Journal of Infectious Diseases, 6, 129-134.
61 Li J., Gerhard D. S., Zhang Z., Huettner P. C., Wright J., Nguyen L., et
al. (2003). Denaturing high-performance liquid chromatography for
detecting and typing genital human papillomavirus. J Clin Microbiol, Vol
41(12), pp. 5563-5571.

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

62 Li Y., Wang Y., Jia C., Ma Y., Lan Y. & Wang S. (2008). Detection of
human papillomavirus genotypes with liquid bead microarray in cervical
lesions of northern Chinese patients. Cancer Genet Cytogenet, Vol
182(1), pp.12-17.
63 Liu J. H. (2004). Risk factors for Cervical Human Papilloma Virus
Infection and Cervical Neoplasia in Southern China and Australia: A
molecular and Epidemiological Analysis. Unpublished A thesis for the
Degree of Doctor of Philosophy.
64 Lorincz, A. T. & Richart, R. M. (2003). Human papillomavirus DNA
testing as an adjunct to cytology in cervical screening programs. Arch
Pathol Lab Med, 127(8), 959-968.
65 Lungu O., Sun X. W., Wright T. C., Ferenczy A., Richart R. M. &
Silverstein S. (1995). A polymerase chain reaction-enzyme-linked
immunosorbent assay method for detecting human papillomavirus in
cervical carcinomas and high-grade cervical cancer precursors. Obstet
Gynecol, Vol 85(3), pp.337-342.
66 Malcolm A. (1996). Cervical intraepithelial – Aetiology natural history
of cervical and inflammatory and infective conditions of the cervix –

Human Papilloma Virus Carcinoma (2 ed.). Chapman and Hall Medical.
67 Manos M. M., Kinney W. K., Hurley L. B., Sherman M. E. & ShiehNgai J. (1999). Identifying women with cervical neoplasia: using human
papillomavirus DNA testing for equivocal Papanicolaou results. Jama,
Vol 281(17), pp.1605-1610.
68 Mark H. S. and Louise A. B. (1995). The Epidemiology of Cervical
Carcinogenesis. Cancer Supplement, 76(10), 1888-1898.
69 Massad L. S., Collins Y. C. & Meyer P. M. (2001). Biopsy correlates of
abnormal cervical cytology classified using the Bethesda system.
Gynecol Oncol, Vol 82(3), pp.516-522.
70 Mayrand M., Eliane D., Rodrigues I., Walter S. D., Hanley J., Ferenczy
A., et al. (2007). Human Papillomavirus DNA versus Papanicolaou
Screening Tests for Cervical Cancer. N Engl J Med, Vol 357(16),

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

pp.1579-1588.
71 Megevand E., Van Wyk W., Knight B. & Bloch B. (1996). Can cervical
cancer be prevented by a see, screen, and treat program? A pilot study.
Am J Obstet Gynecol, Vol 174(3), pp.923-928.
72 Melnikow J., Nuovo J., Willan A. R., Chan B. K. & Howell L. P. (1998).
Natural history of cervical squamous intraepithelial lesions: a metaanalysis. Obstet Gynecol, Vol 92(4), pp. 727-735.
73 Misra JS., Das V., S. A., U.;, S. & Chhavi. (2006). Role of different
etiological factors in progression of cervical intraepithelial neoplasia.
Diagn Cytopathol, 34(10), 682-685.
74 Monsonego J., Pintos J., Semaille C., Beumont M., Dachez R., Zerat L.,
et al. (2006). Human papillomavirus testing improves the accuracy of

colposcopy in detection of cervical intraepithelial neoplasia. Int J
Gynecol Cancer, Vol 16(2), pp. 591-598.
75 Moreno V., Bosch F. X., Munoz N., Meijer C. J., Shah K. V.,
Walboomers J. M., et al. (2002). Effect of oral contraceptives on risk of
cervical cancer in women with human papillomavirus infection: the
IARC multicentric case-control study. Lancet, Vol 359(9312), pp. 10851092.
76 Moscicki A. B., Shiboski S., Hills N. K. & Powell K. J. (2004).
Regression of low-grade squamous intra-epithelial lesions in young
women. Lancet, Vol 364(9446), pp.1678-1683.
77 Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C.
L., Owens, M., et al. (2004). Mechanisms of human papillomavirusinduced oncogenesis. J Virol, 78(21), 11451-11460.
78 Munoz N, B. F. X. (2003). Epidemiologic classification of Human
Papillomavirus types associated with cervical cancers. NEJM, 348, 518527.
79 Munoz N. & Bosch F. X. (2003). Epidemiologic classification of Human
Papillomavirus types associated with cervical cancers. NEJM, 348, 518-

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

527.
80 Munoz N., Franceschi S., Bosetti C., Moreno V., Herrero R., Smith J. S.,
et al. (2002). Role of parity and human papillomavirus in cervical cancer:
the IARC multicentric case-control study. Lancet, Vol 359(9312), pp.
1093-1101.
81 Papanicolaou G. N. (1949). A survey of the actualities and potentialities
of exfoliative cytology in cancer diagnosis. Ann Intern Med, Vol 31(4),
pp.661-674.

82 Parkin D. M., Bray F., Ferlay J. & Pisani P. (2001). Estimating the world
cancer burden: Globocan 2000. Int J Cancer, Vol 94(2), pp.153-156.
83 Pirog E. C., Kleter B., Olgac S., Bobkiewicz P., Lindeman J., Quint W.
G., et al. (2000). Prevalence of human papillomavirus DNA in different
histological subtypes of cervical adenocarcinoma. Am J Pathol, Vol
157(4), pp.1055-1062.
84 Porreco R., Penn I., Droegemueller W., Greer B. & Makowski E. (1995).
Gynecologic malignancies in immunosuppressed organ homograft
recipients. Obstet Gynecol, Vol 45(4), pp.359-364.
85 Rockville. (1999). Evaluation of Cervical Cytology. Agency for Health
Care Policy and Research.
86 Ronnett B. M., Manos M. M., Ransley J. E., Fetterman B. J., Kinney W.
K., Hurley L. B., et al. (1999). Atypical glandular cells of undetermined
significance (AGUS): cytopathologic features, histopathologic results,
and human papillomavirus DNA detection. Hum Pathol, Vol 30(7),
pp.816-825.
87 Rowe L. R., Aldeen W. & Bentz J. S. (2004). Prevalence and typing of
HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL,
and AGC on ThinPrep Pap tests. Diagn Cytopathol, Vol 30(6), pp.426432.
88 Sankaranarayanan R., Wesley R., Somanathan T., Dhakad N.,
Shyamalakumary B., Amma N. S., et al. (1998). Visual inspection of the

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

uterine cervix after the application of acetic acid in the detection of
cervical carcinoma and its precursors. Cancer, Vol 83(10), pp.21502156.

89 Scheurer M. E., Tortolero-Luna G. & Adler-Storthz K. (2005). Human
papillomavirus infection: biology, epidemiology, and prevention. Int J
Gynecol Cancer, 15, 727–746.
90 Silins I., Ryd W., Strand A., Wadell G., Tornberg S. & Hansson B. G.
(2005). Chlamydia trachomatis infection and persistence of human
papillomavirus. Int J Cancer, Vol 116(1), pp.110-115.
91 Silverloo I., Andrae B. & Wilander E. (2009). Value of high-risk HPVDNA testing in the triage of ASCUS. Acta Obstet Gynecol Scand, 88(9),
1006-2010.
92 Sjamsuddin S, Prihartono J & Nuranna L. (1994). Aided visual
inspection: preliminary results of the Indonesian gynoscope assessment.
PATH and AVSC International.
93 Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., et
al. (2007). Human papillomavirus type distribution in invasive cervical
cancer and high-grade cervical lesions: a meta-analysis update. Int J
Cancer, 121(3), 621-632.
94 Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M.,
et al. (2002). The 2001 Bethesda System: terminology for reporting
results of cervical cytology. Jama, Vol 287(16), pp.2114-2119.
95 Solomon D., Schiffman M. & Tarone R. (2001). Comparison of three
management strategies for patients with atypical squamous cells of
undetermined significance: baseline results from a randomized trial. J
Natl Cancer Inst, Vol 93(4), pp.293-299.
96 Swan, D. C., Tucker, R. A., Tortolero-Luna, G., Mitchell, M. F.,
Wideroff, L., Unger, E. R., et al. (1999). Human Papillomavirus (HPV)
DNA Copy Number Is Dependent on Grade of Cervical Disease and
HPV Type. J. Clin. Microbiol., Vol 37(4), 1030-1034.

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.

.

97 Syrjanen K., Ching T. & Aldrighi J. (2008). Previous screening for
cervical cancer among women with cytological and histological
abnormalities. Rev Saude Publica, Vol 42(3), pp. 411-419.
98 Takazawa A, Inoue M & Saito J. (1992). Detection of Human Papilloma
Virus in exfoliated cervical cells using polymerase chain reaction. Int J
Gynaecol obstet, Vol 37(1), pp.13-18.
99 Thomas D. B., Ray R. M., Pardthaisong T., Chutivongse S., Koetsawang
S. & Silpisornkosol S. (1996). Prostitution, condom use, and invasive
squamous cell cervical cancer in Thailand. Am J Epidemiol, Vol 143(8),
pp.779-786.
100 Unger E. R. & Duarte-Franco E. (2001). Human papillomaviruses: into
the new millennium. Obstet Gynecol Clin North Am, Vol 28(4), pp.653666.
101 University of Zimbabwe/JHPIEGO. (1999). Visual inspection with acetic
acid for cervical-cancer screening: test qualities in a primary-care setting.
Cervical Cancer Project. Lancet, Vol 353(9156), pp.869-873.
102 Vaccarella S, Herrero R & Dai M. (2006). Reproductive factors, oral
contraceptive use, and human papillomavirus infection: pooled analysis
of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers
Prev, 15(1), 2148-2153.
103 Venturoli S., Cricca M., Bonvicini F., Giosa F., Pulvirenti F. R., Galli C.,
et al. (2002). Human papillomavirus DNA testing by PCR-ELISA and
hybrid capture II from a single cytological specimen: concordance and
correlation with cytological results. J Clin Virol, Vol 25(2), pp. 177-185.
104 Vernon S. D., Unger E. R. & Williams D. (2000). Comparison of human
papillomavirus detection and typing by cycle sequencing, line blotting,
and hybrid capture. J Clin Microbiol, Vol 38(2), pp.651-655.
105 Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J.

A. & Shah K. V. (1999). Human papillomavirus is a necessary cause of
invasive cervical cancer worldwide. J Pathol, Vol 189(1), pp.12-19.

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.


.

106 Wright T. C., Massad L. S., Dunton C. J., Spitzer M., Wilkinson E. J. &
Solomon D. (2007). 2006 consensus guidelines for the management of
women with abnormal cervical cancer screening tests. Am J Obstet
Gynecol, Vol 197(4), pp.346-355.
107 Wright T. C., J., Schiffman M., Solomon D., Cox J. T. & Garcia F.
(2004). Interim guidance for the use of human papillomavirus DNA
testing as an adjunct to cervical cytology for screening. Obstet Gynecol,
Vol 103(2), pp.304-309.
108 Yeoh G. P., Chan K. W., Lauder I. & Lam M. B. (1999). Evaluation of
the ThinPrep Papanicolaou test in clinical practice: 6-month study of
16,541 cases with histological correlation in 220 cases. Hong Kong Med
J, Vol 5(3), pp.233-239.
109 Young T. K., McNicol P. & Beauvais J. (1997). Factors associated with
human papillomavirus infection detected by polymerase chain reaction
among urban Canadian aboriginal and non-aboriginal women. Sex
Transm Dis, Vol 24(5), pp.293-298.
110 Zhao F., Li N. & Ma J. (2001). Study of the association between human
papillomavirus infection and cervical cancer in Xianguan county, Shanxi
province. Zhonghua Liu Vol 22(5), pp.375-378.
111 Verguts J., Bronselaer B., Donders G., Arbyn M., Van E. J. &
Drijkoningen M. (2006). Prediction of recurrence after treatment for

high-grade cervical intraepithelial neoplasia: the role of human
papillomavirus testing and age at conisation. Bjog, 113(11), 1303-1307.

Tuân thủ Luật Sở hữu trí tuệ và Quy định truy cập tài liệu điện tử.
Ghi rõ nguồn tài liệu này khi trích dẫn.